Pupil expander
Latest Novartis AG Patents:
- Method of manufacturing bispecific antibodies, bispecific antibodies and therapeutic use of such antibodies
- Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
- CD19 and CD22 chimeric antigen receptors and uses thereof
- Treatment of cancer using GFR alpha-4 chimeric antigen receptor
- Tricyclic AKR1C3 dependent KARS inhibitors
Description
Claims
The ornamental design for a pupil expander, as shown and described.
Referenced Cited
U.S. Patent Documents
3998217 | December 21, 1976 | Trumbull et al. |
5163419 | November 17, 1992 | Goldman |
6440065 | August 27, 2002 | Hered |
6497700 | December 24, 2002 | LaHaye |
6620098 | September 16, 2003 | Milverton |
D489130 | April 27, 2004 | Sinding |
D504721 | May 3, 2005 | Dorfman |
D505203 | May 17, 2005 | Sinding |
D533664 | December 12, 2006 | Buttler et al. |
D535024 | January 9, 2007 | Huttner |
D536094 | January 30, 2007 | Huttner |
D581531 | November 25, 2008 | Alinsod et al. |
D617455 | June 8, 2010 | Mori et al. |
D630736 | January 11, 2011 | Wang |
D686729 | July 23, 2013 | Christensen et al. |
D711536 | August 19, 2014 | Velghe et al. |
20020022211 | February 21, 2002 | Horiguchi |
20070208228 | September 6, 2007 | Pavento et al. |
20070238933 | October 11, 2007 | Alinsod et al. |
Patent History
Patent number: D756515
Type: Grant
Filed: Mar 10, 2014
Date of Patent: May 17, 2016
Assignee: Novartis AG (Basel)
Inventors: Hsin S. Chin (Foothill Ranch, CA), James Y. Chon (Irivne, CA), Rudolph F. Zacher (Costa Mesa, CA)
Primary Examiner: Ian Simmons
Assistant Examiner: Carissa C Fitts
Application Number: 29/484,423
Type: Grant
Filed: Mar 10, 2014
Date of Patent: May 17, 2016
Assignee: Novartis AG (Basel)
Inventors: Hsin S. Chin (Foothill Ranch, CA), James Y. Chon (Irivne, CA), Rudolph F. Zacher (Costa Mesa, CA)
Primary Examiner: Ian Simmons
Assistant Examiner: Carissa C Fitts
Application Number: 29/484,423
Classifications